Goldberg S., Roskosch N.
W.A. Bachofen AG & Glen Mills Inc., US
Keywords: API nanoparticles, bead milling, comminution, DYNO-MILL, size reduction, wet milling
The production of nanoparticles in the size range of 13nm has been achieved using the DYNO®-MILL bead mill. Active Pharmaceutical Ingredients (API) are able to be absorbed by the body’s cells when of a size small enough to mimic “soluble” drug adsorption through the cell walls. These minute particles have been achieved by users of the DYNO®-MILL (W. A. Bachofen AG, Basel, Switzerland) b y employing specialized process conditions and advanced equipment construction. The use of zirconium oxide based ceramic parts, tight tolerances on machine components, and grinding media (beads) below 500mm is revealed. This technology now allows for the production of nanosized API’s on a commercial scale.
Journal: TechConnect Briefs
Volume: 1, Nanotechnology 2008: Materials, Fabrication, Particles, and Characterization – Technical Proceedings of the 2008 NSTI Nanotechnology Conference and Trade Show, Volume 1
Published: June 1, 2008
Pages: 733 - 736
Industry sector: Advanced Materials & Manufacturing
Topic: Nanoparticle Synthesis & Applications
ISBN: 978-1-4200-8503-7